Akero Therapeutics, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 734 matching filings.

Per page

25

Current page

8

4

4

Filing date: 18 Dec 2024
Reporting date: 16 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Dec 2024
Reporting date: 16 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Dec 2024
Reporting date: 16 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Dec 2024
Reporting date: 16 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Dec 2024
Reporting date: 16 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Dec 2024
Reporting date: 16 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Dec 2024
Reporting date: 16 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-38944

144 filing

Filing date: 16 Dec 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 12 Dec 2024
Reporting date: 10 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 12 Dec 2024
Reporting date: 10 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 12 Dec 2024
Reporting date: 10 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 12 Dec 2024
Reporting date: 10 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 12 Dec 2024
Reporting date: 10 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 12 Dec 2024
Reporting date: 10 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-38944

144 filing

Filing date: 10 Dec 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Dec 2024
Reporting date: 02 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 19 Nov 2024
Reporting date: 15 Nov 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91047

JANUS AMENDMENT

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91047

SC 13G/A filing

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91047

AKERO THERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91047

AKERO THERAPEUTICS, INC.

Filing date: 13 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 08 Nov 2024
Reporting date: 06 Nov 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91047

SEC SCHEDULE 13G

Filing date: 08 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38944

10-Q

Filing date: 08 Nov 2024
Reporting date: 30 Sep 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .